Literature DB >> 10482552

The simian immunodeficiency virus envelope glycoprotein contains two epitopes presented by the Mamu-A*01 class I molecule.

M Furchner1, A L Erickson, T Allen, D I Watkins, A Sette, P R Johnson, C M Walker.   

Abstract

Cytotoxic T lymphocyte (CTL) responses against the simian immunodeficiency virus (SIV) envelope and Gag proteins were monitored in a Mamu-A*01-positive rhesus macaque infected with SIVsmE660. Peripheral blood mononuclear cells (PBMC) cultured with synthetic peptides spanning the entire gp160 and Gag coding region recognized a total of three epitopes. One located in Gag was identified as the previously described Mamu-A*01-restricted p11cC-->M epitope (CTPYDINQM). The other two epitopes, designated p15m and p54m, were located in the gp160 envelope protein. Both were nine amino acids in length and were predicted to bind Mamu-A*01 because they contained proline and leucine residues at positions 3 and 9, respectively. Indeed, expression of this class I major histocompatibility complex molecule was required for target cell recognition by envelope-specific CD8(+) T cells directed against both epitopes. These Mamu-A*01-restricted epitopes in the SIV envelope will be useful for monitoring immune responses in vaccinated or infected animals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482552      PMCID: PMC112819          DOI: 10.1128/JVI.73.10.8035-8039.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

2.  An African primate lentivirus (SIVsm) closely related to HIV-2.

Authors:  V M Hirsch; R A Olmsted; M Murphey-Corb; R H Purcell; P R Johnson
Journal:  Nature       Date:  1989-06-01       Impact factor: 49.962

3.  Simian immunodeficiency virus infection of macaques: end-stage disease is characterized by widespread distribution of proviral DNA in tissues.

Authors:  V M Hirsch; P M Zack; A P Vogel; P R Johnson
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

4.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

Authors:  G S Ogg; X Jin; S Bonhoeffer; P R Dunbar; M A Nowak; S Monard; J P Segal; Y Cao; S L Rowland-Jones; V Cerundolo; A Hurley; M Markowitz; D D Ho; D F Nixon; A J McMichael
Journal:  Science       Date:  1998-03-27       Impact factor: 47.728

5.  In vivo migration and function of transferred HIV-1-specific cytotoxic T cells.

Authors:  S J Brodie; D A Lewinsohn; B K Patterson; D Jiyamapa; J Krieger; L Corey; P D Greenberg; S R Riddell
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

6.  A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication.

Authors:  C M Walker; J A Levy
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

7.  Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.

Authors:  T M Allen; J Sidney; M F del Guercio; R L Glickman; G L Lensmeyer; D A Wiebe; R DeMars; C D Pauza; R P Johnson; A Sette; D I Watkins
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

8.  CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.

Authors:  C M Walker; D J Moody; D P Stites; J A Levy
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

9.  A new look at T cells.

Authors:  A J McMichael; C A O'Callaghan
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

10.  A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes.

Authors:  H Tsubota; C I Lord; D I Watkins; C Morimoto; N L Letvin
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  13 in total

1.  Transcriptionally abundant major histocompatibility complex class I alleles are fundamental to nonhuman primate simian immunodeficiency virus-specific CD8+ T cell responses.

Authors:  Melisa L Budde; Jennifer J Lhost; Benjamin J Burwitz; Ericka A Becker; Charles M Burns; Shelby L O'Connor; Julie A Karl; Roger W Wiseman; Benjamin N Bimber; Guang Lan Zhang; William Hildebrand; Vladimir Brusic; David H O'Connor
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques.

Authors:  Philip R Johnson; Bruce C Schnepp; Mary J Connell; Daniela Rohne; Suzanne Robinson; Georgia R Krivulka; Carol I Lord; Rebekah Zinn; David C Montefiori; Norman L Letvin; K Reed Clark
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little.

Authors:  Matthew R Reynolds; Eva Rakasz; Pamela J Skinner; Cara White; Kristina Abel; Zhong-Min Ma; Lara Compton; Gnankang Napoé; Nancy Wilson; Christopher J Miller; Ashley Haase; David I Watkins
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression.

Authors:  D T Evans; P Jing; T M Allen; D H O'Connor; H Horton; J E Venham; M Piekarczyk; J Dzuris; M Dykhuzen; J Mitchen; R A Rudersdorf; C D Pauza; A Sette; R E Bontrop; R DeMars; D I Watkins
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.

Authors:  T M Allen; B R Mothé; J Sidney; P Jing; J L Dzuris; M E Liebl; T U Vogel; D H O'Connor; X Wang; M C Wussow; J A Thomson; J D Altman; D I Watkins; A Sette
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  Simian immunodeficiency virus (SIV) infection of a rhesus macaque induces SIV-specific CD8(+) T cells with a defect in effector function that is reversible on extended interleukin-2 incubation.

Authors:  Y Xiong; M A Luscher; J D Altman; M Hulsey; H L Robinson; M Ostrowski; B H Barber; K S MacDonald
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity.

Authors:  Alessandro Sette; John Sidney; Huynh-Hoa Bui; Marie-France del Guercio; Jeff Alexander; John Loffredo; David I Watkins; Bianca R Mothé
Journal:  Immunogenetics       Date:  2005-03-04       Impact factor: 2.846

8.  Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.

Authors:  J L Dzuris; J Sidney; H Horton; R Correa; D Carter; R W Chesnut; D I Watkins; A Sette
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Evolutionary stability of MHC class II haplotypes in diverse rhesus macaque populations.

Authors:  Gaby G M Doxiadis; Nel Otting; Natasja G de Groot; Nanine de Groot; Annemiek J M Rouweler; Riet Noort; Ernst J Verschoor; Ilja Bontjer; Ronald E Bontrop
Journal:  Immunogenetics       Date:  2003-10-18       Impact factor: 2.846

10.  Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes.

Authors:  Masahiko Kaizu; Gretta J Borchardt; Chrystal E Glidden; Debra L Fisk; John T Loffredo; David I Watkins; William M Rehrauer
Journal:  Immunogenetics       Date:  2007-07-20       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.